Switch theme
Sign up to access all valuation multiples
Chengzhi Co Ltd, formerly Chengzhi Shareholding Co Ltd is a China-based company engaged in the businesses of clean energy, functional materials and medical care and health.
1998
1.7K+
LTM Revenue n/a
LTM EBITDA n/a
$1.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Chengzhi has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Chengzhi achieved revenue of $1.5B and an EBITDA of $173M.
Chengzhi expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Chengzhi valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.7B | $1.5B | XXX | XXX | XXX |
| Gross Profit | $181M | $225M | XXX | XXX | XXX |
| Gross Margin | 11% | 15% | XXX | XXX | XXX |
| EBITDA | $163M | $173M | XXX | XXX | XXX |
| EBITDA Margin | 10% | 11% | XXX | XXX | XXX |
| Net Profit | $7.3M | $24.3M | XXX | XXX | XXX |
| Net Margin | 0% | 2% | XXX | XXX | XXX |
| Net Debt | $254M | $170M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 25, 2025, Chengzhi's stock price is CNY 8 (or $1).
Chengzhi has current market cap of CNY 9.3B (or $1.3B), and EV of CNY 11.2B (or $1.5B).
See Chengzhi trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.5B | $1.3B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 25, 2025, Chengzhi has market cap of $1.3B and EV of $1.5B.
Chengzhi's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Chengzhi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Chengzhi and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.5B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 8.9x | XXX | XXX | XXX |
| P/E | 40.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 62.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpChengzhi's NTM/LTM revenue growth is n/a
Chengzhi's revenue per employee for the last fiscal year averaged $0.9M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Chengzhi's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Chengzhi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Chengzhi and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -11% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.9M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 8% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| XXX | XXX | XXX | XXX | XXX | XXX | |
| Merck KGaA | XXX | XXX | XXX | XXX | XXX | XXX |
| Posco Future | XXX | XXX | XXX | XXX | XXX | XXX |
| Cosmo Advanced Materials | XXX | XXX | XXX | XXX | XXX | XXX |
| Daejoo Electronic | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chengzhi acquired XXX companies to date.
Last acquisition by Chengzhi was XXXXXXXX, XXXXX XXXXX XXXXXX . Chengzhi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Chengzhi founded? | Chengzhi was founded in 1998. |
| Where is Chengzhi headquartered? | Chengzhi is headquartered in China. |
| How many employees does Chengzhi have? | As of today, Chengzhi has 1.7K+ employees. |
| Is Chengzhi publicy listed? | Yes, Chengzhi is a public company listed on SHE. |
| What is the stock symbol of Chengzhi? | Chengzhi trades under 000990 ticker. |
| When did Chengzhi go public? | Chengzhi went public in 2000. |
| Who are competitors of Chengzhi? | Similar companies to Chengzhi include e.g. , Merck KGaA, Posco Future, Cosmo Advanced Materials. |
| What is the current market cap of Chengzhi? | Chengzhi's current market cap is $1.3B |
| What is the current revenue growth of Chengzhi? | Chengzhi revenue growth between 2023 and 2024 was -11%. |
| Is Chengzhi profitable? | Yes, Chengzhi is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
